Luna Innovations Incorporated announces Krishan Kumar, Ph.D., has joined the company as Vice President of Research and Development (R&D) at its Luna nanoWorks division in Danville, Va. In this role, Kumar will be providing strategic and tactical leadership to the R&D team of Luna nanoWorks.
Kumar is an accomplished pharmaceutical manager and scientist with 19 years of pharmaceutical industry experience. Prior to joining Luna nanoWorks, he held several management positions with Merial Ltd. (a Merck and sanofi-aventis Co.), including Executive Director of Pharmaceutical Sciences and Technology and Executive Director of Pharmaceutical Product Development. During his tenure with Merial, he led the Pharmaceutical Product Development group (including formulation, process, analytical and pharmacokinetics and drug metabolism) that supported world-wide registrations of several products.
“We are delighted to have the opportunity to add someone of Dr. Kumar’s caliber to our senior management team,” said Robert Lenk, Ph.D., President of the nanoWorks Division. “His vast experience will help us to accelerate the translation of our exciting discoveries of diagnostic and therapeutic nanoMedicines into product candidates that we hope will successfully negotiate the rigorous FDA approval process and eventually change the management of many significant diseases.”
Kumar also played a key role in establishing a new state-of-the-art Reference Standards Laboratory at the United States Pharmacopeia (USP) where he served as Laboratory Director. Additionally he has worked at Bristol Myers Squibb, Bracco Research USA, and the National Cancer Institute. As a recognized expert in the pharmaceutical industry, he has served on the expert committees of the USP and chaired an American Association of Pharmaceutical Scientists focus group.
Kumar received his doctorate in Chemistry from the Indian Institute of Technology, and his bachelor’s and master’s degrees in Chemistry from Agra University. For more information on Luna Innovations, see www.lunainnovations.com.
About Luna Innovations:
Luna Innovations Incorporated develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. Our products are used to measure, monitor, protect and improve critical processes in the markets we serve. Luna nanoWorks is a division of Luna Innovations. With a world-class nanomaterial manufacturing facility in Danville, Virginia, the nanoWorks Division is developing products empowered by nanomaterials with applications in diagnostics, therapeutics, and organic solar cells. For more information visit www.lunananoworks.com.
Forward Looking Statements:
This release includes information that constitutes “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements regarding, but not limited to: the development of nanotechnologies into marketable pharmaceutical, medical, or other products and Luna’s ability to pursue business opportunities in new markets. Statements that describe the Company’s business strategy, goals, prospects, opportunities, outlook, plans or intentions are also forward looking statements. Actual results may differ materially from the expectations expressed in such forward-looking statements as a result of various factors, including risks and uncertainties set forth in the company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at http://www.sec.gov, and at the company’s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release and Luna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.